Full Press Release Details
MORRISTOWN, N.J.,Sept. 2, 2025/PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq:WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, announced today that the Company's president and CEO,Dave Lennon, PhD, will participate in a fireside chat during the following upcoming investor conferences inNew York City, NY:
A live webcast of the fireside chat events can be accessed by visiting the Whitehawk Therapeutics IRwebsite. These will be available for replay for approximately 30 days following the event.
About Whitehawk TherapeuticsWhitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from WuXi Biologics under an exclusive development and global commercialization agreement. More information on the Company is available atwww.whitehawktx.comand connect with us on LinkedIn.
Contact[email protected]
SOURCE Whitehawk Therapeutics, Inc.